APO Research
Talk to an analyst

APO RESEARCH · REPORT

Haloperidol

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Haloperidol Market Analysis and Forecast 2026-2032

27 December 2025192 pages

Choose your research edition.

Industry ResearchHaloperidol Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Haloperidol Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Haloperidol Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Haloperidol Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Haloperidol Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Haloperidol market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Haloperidol is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Haloperidol is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Haloperidol is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Haloperidol is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Haloperidol include Teva, Sandoz, Mylan, Zydus, Gland Pharma and Fresenius Kabi, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Haloperidol, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Haloperidol, also provides the sales of main regions and countries. Of the upcoming market potential for Haloperidol, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Haloperidol sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Haloperidol market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Haloperidol sales, projected growth trends, production technology, application and end-user industry.

Haloperidol Segment by Company

Teva

Sandoz

Mylan

Zydus

Gland Pharma

Fresenius Kabi

Haloperidol Segment by Type

Oral

Injection

Haloperidol Segment by Application

Mental Disease

Others

Haloperidol Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Haloperidol market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Haloperidol and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Haloperidol.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Haloperidol in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Haloperidol manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Haloperidol sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Haloperidol Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Oral Major Manufacturers Table 3. Injection Major Manufacturers Table 4. Global Haloperidol Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Mental Disease Major Manufacturers Table 6. Others Major Manufacturers Table 7. Haloperidol Industry Trends Table 8. Haloperidol Industry Drivers Table 9. Haloperidol Industry Opportunities and Challenges Table 10. Haloperidol Industry Restraints Table 11. Global Haloperidol Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Haloperidol Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Haloperidol Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Haloperidol Revenue Market Share by Region (2021-2026) Table 15. Global Haloperidol Revenue Market Share by Region (2027-2032) Table 16. Global Haloperidol Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Tons) Table 17. Global Haloperidol Sales by Region (2021-2026) & (Tons) Table 18. Global Haloperidol Sales by Region (2027-2032) & (Tons) Table 19. Global Haloperidol Sales Market Share by Region (2021-2026) Table 20. Global Haloperidol Sales Market Share by Region (2027-2032) Table 21. Global Haloperidol Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Haloperidol Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Haloperidol Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Haloperidol Sales Market Share by Manufacturers (2021-2026) Table 25. Global Haloperidol Sales Price (US$/Ton) of Manufacturers (2021-2026) Table 26. Global Haloperidol Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Haloperidol Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Haloperidol Manufacturers, Product Type & Application Table 29. Global Haloperidol Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Haloperidol by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Haloperidol Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Haloperidol Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Haloperidol Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Haloperidol Revenue Market Share by Type (2021-2026) Table 36. Global Haloperidol Revenue Market Share by Type (2027-2032) Table 37. Global Haloperidol Sales by Type 2021 VS 2025 VS 2032 (Tons) Table 38. Global Haloperidol Sales by Type (2021-2026) & (Tons) Table 39. Global Haloperidol Sales by Type (2027-2032) & (Tons) Table 40. Global Haloperidol Sales Market Share by Type (2021-2026) Table 41. Global Haloperidol Sales Market Share by Type (2027-2032) Table 42. Global Haloperidol Price by Type (2021-2026) & (US$/Ton) Table 43. Global Haloperidol Price by Type (2027-2032) & (US$/Ton) Table 44. Global Haloperidol Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Haloperidol Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Haloperidol Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Haloperidol Revenue Market Share by Application (2021-2026) Table 48. Global Haloperidol Revenue Market Share by Application (2027-2032) Table 49. Global Haloperidol Sales by Application 2021 VS 2025 VS 2032 (Tons) Table 50. Global Haloperidol Sales by Application (2021-2026) & (Tons) Table 51. Global Haloperidol Sales by Application (2027-2032) & (Tons) Table 52. Global Haloperidol Sales Market Share by Application (2021-2026) Table 53. Global Haloperidol Sales Market Share by Application (2027-2032) Table 54. Global Haloperidol Price by Application (2021-2026) & (US$/Ton) Table 55. Global Haloperidol Price by Application (2027-2032) & (US$/Ton) Table 56. Teva Company Information Table 57. Teva Business Overview Table 58. Teva Haloperidol Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 59. Teva Haloperidol Product Portfolio Table 60. Teva Recent Development Table 61. Sandoz Company Information Table 62. Sandoz Business Overview Table 63. Sandoz Haloperidol Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 64. Sandoz Haloperidol Product Portfolio Table 65. Sandoz Recent Development Table 66. Mylan Company Information Table 67. Mylan Business Overview Table 68. Mylan Haloperidol Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 69. Mylan Haloperidol Product Portfolio Table 70. Mylan Recent Development Table 71. Zydus Company Information Table 72. Zydus Business Overview Table 73. Zydus Haloperidol Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 74. Zydus Haloperidol Product Portfolio Table 75. Zydus Recent Development Table 76. Gland Pharma Company Information Table 77. Gland Pharma Business Overview Table 78. Gland Pharma Haloperidol Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 79. Gland Pharma Haloperidol Product Portfolio Table 80. Gland Pharma Recent Development Table 81. Fresenius Kabi Company Information Table 82. Fresenius Kabi Business Overview Table 83. Fresenius Kabi Haloperidol Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 84. Fresenius Kabi Haloperidol Product Portfolio Table 85. Fresenius Kabi Recent Development Table 86. North America Haloperidol Revenue by Type (2021-2026) & (US$ Million) Table 87. North America Haloperidol Revenue by Type (2027-2032) & (US$ Million) Table 88. North America Haloperidol Sales by Type (2021-2026) & (Tons) Table 89. North America Haloperidol Sales by Type (2027-2032) & (Tons) Table 90. North America Haloperidol Sales Price by Type (2021-2026) & (US$/Ton) Table 91. North America Haloperidol Sales Price by Type (2027-2032) & (US$/Ton) Table 92. North America Haloperidol Revenue by Application (2021-2026) & (US$ Million) Table 93. North America Haloperidol Revenue by Application (2027-2032) & (US$ Million) Table 94. North America Haloperidol Sales by Application (2021-2026) & (Tons) Table 95. North America Haloperidol Sales by Application (2027-2032) & (Tons) Table 96. North America Haloperidol Sales Price by Application (2021-2026) & (US$/Ton) Table 97. North America Haloperidol Sales Price by Application (2027-2032) & (US$/Ton) Table 98. North America Haloperidol Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 99. North America Haloperidol Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 100. North America Haloperidol Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 101. North America Haloperidol Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 102. North America Haloperidol Sales by Country (2021-2026) & (Tons) Table 103. North America Haloperidol Sales by Country (2027-2032) & (Tons) Table 104. North America Haloperidol Sales Price by Country (2021-2026) & (US$/Ton) Table 105. North America Haloperidol Sales Price by Country (2027-2032) & (US$/Ton) Table 106. United States Haloperidol Revenue (2021-2032) & (US$ Million) Table 107. Canada Haloperidol Revenue (2021-2032) & (US$ Million) Table 108. Mexico Haloperidol Revenue (2021-2032) & (US$ Million) Table 109. Europe Haloperidol Revenue by Type (2021-2026) & (US$ Million) Table 110. Europe Haloperidol Revenue by Type (2027-2032) & (US$ Million) Table 111. Europe Haloperidol Sales by Type (2021-2026) & (Tons) Table 112. Europe Haloperidol Sales by Type (2027-2032) & (Tons) Table 113. Europe Haloperidol Sales Price by Type (2021-2026) & (US$/Ton) Table 114. Europe Haloperidol Sales Price by Type (2027-2032) & (US$/Ton) Table 115. Europe Haloperidol Revenue by Application (2021-2026) & (US$ Million) Table 116. Europe Haloperidol Revenue by Application (2027-2032) & (US$ Million) Table 117. Europe Haloperidol Sales by Application (2021-2026) & (Tons) Table 118. Europe Haloperidol Sales by Application (2027-2032) & (Tons) Table 119. Europe Haloperidol Sales Price by Application (2021-2026) & (US$/Ton) Table 120. Europe Haloperidol Sales Price by Application (2027-2032) & (US$/Ton) Table 121. Europe Haloperidol Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 122. Europe Haloperidol Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 123. Europe Haloperidol Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 124. Europe Haloperidol Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 125. Europe Haloperidol Sales by Country (2021-2026) & (Tons) Table 126. Europe Haloperidol Sales by Country (2027-2032) & (Tons) Table 127. Europe Haloperidol Sales Price by Country (2021-2026) & (US$/Ton) Table 128. Europe Haloperidol Sales Price by Country (2027-2032) & (US$/Ton) Table 129. Germany Haloperidol Revenue (2021-2032) & (US$ Million) Table 130. France Haloperidol Revenue (2021-2032) & (US$ Million) Table 131. U.K. Haloperidol Revenue (2021-2032) & (US$ Million) Table 132. Italy Haloperidol Revenue (2021-2032) & (US$ Million) Table 133. Russia Haloperidol Revenue (2021-2032) & (US$ Million) Table 134. Spain Haloperidol Revenue (2021-2032) & (US$ Million) Table 135. Netherlands Haloperidol Revenue (2021-2032) & (US$ Million) Table 136. Switzerland Haloperidol Revenue (2021-2032) & (US$ Million) Table 137. Sweden Haloperidol Revenue (2021-2032) & (US$ Million) Table 138. Poland Haloperidol Revenue (2021-2032) & (US$ Million) Table 139. China Haloperidol Revenue by Type (2021-2026) & (US$ Million) Table 140. China Haloperidol Revenue by Type (2027-2032) & (US$ Million) Table 141. China Haloperidol Sales by Type (2021-2026) & (Tons) Table 142. China Haloperidol Sales by Type (2027-2032) & (Tons) Table 143. China Haloperidol Sales Price by Type (2021-2026) & (US$/Ton) Table 144. China Haloperidol Sales Price by Type (2027-2032) & (US$/Ton) Table 145. China Haloperidol Revenue by Application (2021-2026) & (US$ Million) Table 146. China Haloperidol Revenue by Application (2027-2032) & (US$ Million) Table 147. China Haloperidol Sales by Application (2021-2026) & (Tons) Table 148. China Haloperidol Sales by Application (2027-2032) & (Tons) Table 149. China Haloperidol Sales Price by Application (2021-2026) & (US$/Ton) Table 150. China Haloperidol Sales Price by Application (2027-2032) & (US$/Ton) Table 151. Asia Haloperidol Revenue by Type (2021-2026) & (US$ Million) Table 152. Asia Haloperidol Revenue by Type (2027-2032) & (US$ Million) Table 153. Asia Haloperidol Sales by Type (2021-2026) & (Tons) Table 154. Asia Haloperidol Sales by Type (2027-2032) & (Tons) Table 155. Asia Haloperidol Sales Price by Type (2021-2026) & (US$/Ton) Table 156. Asia Haloperidol Sales Price by Type (2027-2032) & (US$/Ton) Table 157. Asia Haloperidol Revenue by Application (2021-2026) & (US$ Million) Table 158. Asia Haloperidol Revenue by Application (2027-2032) & (US$ Million) Table 159. Asia Haloperidol Sales by Application (2021-2026) & (Tons) Table 160. Asia Haloperidol Sales by Application (2027-2032) & (Tons) Table 161. Asia Haloperidol Sales Price by Application (2021-2026) & (US$/Ton) Table 162. Asia Haloperidol Sales Price by Application (2027-2032) & (US$/Ton) Table 163. Asia Haloperidol Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 164. Asia Haloperidol Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 165. Asia Haloperidol Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 166. Asia Haloperidol Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 167. Asia Haloperidol Sales by Country (2021-2026) & (Tons) Table 168. Asia Haloperidol Sales by Country (2027-2032) & (Tons) Table 169. Asia Haloperidol Sales Price by Country (2021-2026) & (US$/Ton) Table 170. Asia Haloperidol Sales Price by Country (2027-2032) & (US$/Ton) Table 171. Japan Haloperidol Revenue (2021-2032) & (US$ Million) Table 172. South Korea Haloperidol Revenue (2021-2032) & (US$ Million) Table 173. India Haloperidol Revenue (2021-2032) & (US$ Million) Table 174. Australia Haloperidol Revenue (2021-2032) & (US$ Million) Table 175. Taiwan Haloperidol Revenue (2021-2032) & (US$ Million) Table 176. Southeast Asia Haloperidol Revenue (2021-2032) & (US$ Million) Table 177. SAMEA Haloperidol Revenue by Type (2021-2026) & (US$ Million) Table 178. SAMEA Haloperidol Revenue by Type (2027-2032) & (US$ Million) Table 179. SAMEA Haloperidol Sales by Type (2021-2026) & (Tons) Table 180. SAMEA Haloperidol Sales by Type (2027-2032) & (Tons) Table 181. SAMEA Haloperidol Sales Price by Type (2021-2026) & (US$/Ton) Table 182. SAMEA Haloperidol Sales Price by Type (2027-2032) & (US$/Ton) Table 183. SAMEA Haloperidol Revenue by Application (2021-2026) & (US$ Million) Table 184. SAMEA Haloperidol Revenue by Application (2027-2032) & (US$ Million) Table 185. SAMEA Haloperidol Sales by Application (2021-2026) & (Tons) Table 186. SAMEA Haloperidol Sales by Application (2027-2032) & (Tons) Table 187. SAMEA Haloperidol Sales Price by Application (2021-2026) & (US$/Ton) Table 188. SAMEA Haloperidol Sales Price by Application (2027-2032) & (US$/Ton) Table 189. SAMEA Haloperidol Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 190. SAMEA Haloperidol Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 191. SAMEA Haloperidol Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 192. SAMEA Haloperidol Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 193. SAMEA Haloperidol Sales by Country (2021-2026) & (Tons) Table 194. SAMEA Haloperidol Sales by Country (2027-2032) & (Tons) Table 195. SAMEA Haloperidol Sales Price by Country (2021-2026) & (US$/Ton) Table 196. SAMEA Haloperidol Sales Price by Country (2027-2032) & (US$/Ton) Table 197. Brazil Haloperidol Revenue (2021-2032) & (US$ Million) Table 198. Argentina Haloperidol Revenue (2021-2032) & (US$ Million) Table 199. Chile Haloperidol Revenue (2021-2032) & (US$ Million) Table 200. Colombia Haloperidol Revenue (2021-2032) & (US$ Million) Table 201. Peru Haloperidol Revenue (2021-2032) & (US$ Million) Table 202. Saudi Arabia Haloperidol Revenue (2021-2032) & (US$ Million) Table 203. Israel Haloperidol Revenue (2021-2032) & (US$ Million) Table 204. UAE Haloperidol Revenue (2021-2032) & (US$ Million) Table 205. Turkey Haloperidol Revenue (2021-2032) & (US$ Million) Table 206. Iran Haloperidol Revenue (2021-2032) & (US$ Million) Table 207. Egypt Haloperidol Revenue (2021-2032) & (US$ Million) Table 208. Key Raw Materials Table 209. Raw Materials Key Suppliers Table 210. Haloperidol Distributors List Table 211. Haloperidol Customers List Table 212. Research Programs/Design for This Report Table 213. Authors List of This Report Table 214. Secondary Sources Table 215. Primary Sources List of Figures Figure 1. Haloperidol Image Figure 2. Global Haloperidol Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Haloperidol Market Size Share 2021 VS 2025 VS 2032 Figure 4. Oral Image Figure 5. Injection Image Figure 6. Global Haloperidol Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Haloperidol Market Size Share 2021 VS 2025 VS 2032 Figure 8. Mental Disease Image Figure 9. Others Image Figure 10. Global Haloperidol Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Haloperidol Revenue (2021-2032) & (US$ Million) Figure 12. Global Haloperidol Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Haloperidol Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Haloperidol Revenue Market Share by Region (2021-2032) Figure 15. Global Haloperidol Sales (2021-2032) & (Tons) Figure 16. Global Haloperidol Sales by Region: 2021 VS 2025 VS 2032 (Tons) Figure 17. Global Haloperidol Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Haloperidol Sales YoY (2021-2032) & (Tons) Figure 19. Europe Haloperidol Sales YoY (2021-2032) & (Tons) Figure 20. China Haloperidol Sales YoY (2021-2032) & (Tons) Figure 21. Asia (Excluding China) Haloperidol Sales YoY (2021-2032) & (Tons) Figure 22. South America, Middle East and Africa Haloperidol Sales YoY (2021-2032) & (Tons) Figure 23. Global Haloperidol Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Haloperidol Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Haloperidol Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Haloperidol Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Haloperidol Revenue Market Share by Type (2021-2032) Figure 29. Global Haloperidol Sales by Type (2021 VS 2025 VS 2032) & (Tons) Figure 30. Global Haloperidol Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Haloperidol Sales Market Share by Type (2021-2032) Figure 32. Global Haloperidol Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Haloperidol Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Haloperidol Revenue Market Share by Application (2021-2032) Figure 35. Global Haloperidol Sales by Application (2021 VS 2025 VS 2032) & (Tons) Figure 36. Global Haloperidol Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Haloperidol Sales Market Share by Application (2021-2032) Figure 38. North America Haloperidol Revenue Share by Type (2021-2032) Figure 39. North America Haloperidol Sales Share by Type (2021-2032) Figure 40. North America Haloperidol Revenue Share by Application (2021-2032) Figure 41. North America Haloperidol Sales Share by Application (2021-2032) Figure 42. North America Haloperidol Revenue Share by Country (2021-2032) Figure 43. North America Haloperidol Sales Share by Country (2021-2032) Figure 44. Europe Haloperidol Revenue Share by Type (2021-2032) Figure 45. Europe Haloperidol Sales Share by Type (2021-2032) Figure 46. Europe Haloperidol Revenue Share by Application (2021-2032) Figure 47. Europe Haloperidol Sales Share by Application (2021-2032) Figure 48. Europe Haloperidol Revenue Share by Country (2021-2032) Figure 49. Europe Haloperidol Sales Share by Country (2021-2032) Figure 50. China Haloperidol Revenue Share by Type (2021-2032) Figure 51. China Haloperidol Sales Share by Type (2021-2032) Figure 52. China Haloperidol Revenue Share by Application (2021-2032) Figure 53. China Haloperidol Sales Share by Application (2021-2032) Figure 54. Asia Haloperidol Revenue Share by Type (2021-2032) Figure 55. Asia Haloperidol Sales Share by Type (2021-2032) Figure 56. Asia Haloperidol Revenue Share by Application (2021-2032) Figure 57. Asia Haloperidol Sales Share by Application (2021-2032) Figure 58. Asia Haloperidol Revenue Share by Country (2021-2032) Figure 59. Asia Haloperidol Sales Share by Country (2021-2032) Figure 60. SAMEA Haloperidol Revenue Share by Type (2021-2032) Figure 61. SAMEA Haloperidol Sales Share by Type (2021-2032) Figure 62. SAMEA Haloperidol Revenue Share by Application (2021-2032) Figure 63. SAMEA Haloperidol Sales Share by Application (2021-2032) Figure 64. SAMEA Haloperidol Revenue Share by Country (2021-2032) Figure 65. SAMEA Haloperidol Sales Share by Country (2021-2032) Figure 66. Haloperidol Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Haloperidol Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Oral
  • Injection
Applications
  • Mental Disease
  • Others
Companies covered
  • Teva
  • Sandoz
  • Mylan
  • Zydus
  • Gland Pharma
  • Fresenius Kabi

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Haloperidol Market by Type
  3. 1.2.1 Global Haloperidol Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Oral
  5. 1.2.3 Injection
  6. 1.3 Haloperidol Market by Application
  7. 1.3.1 Global Haloperidol Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Mental Disease
  9. 1.3.3 Others
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Haloperidol Market Dynamics
  1. 2.1 Haloperidol Industry Trends
  2. 2.2 Haloperidol Industry Drivers
  3. 2.3 Haloperidol Industry Opportunities and Challenges
  4. 2.4 Haloperidol Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Haloperidol Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Haloperidol Revenue by Region
  3. 3.2.1 Global Haloperidol Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Haloperidol Revenue by Region (2021-2026)
  5. 3.2.3 Global Haloperidol Revenue by Region (2027-2032)
  6. 3.2.4 Global Haloperidol Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Haloperidol Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Haloperidol Sales by Region
  9. 3.4.1 Global Haloperidol Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Haloperidol Sales by Region (2021-2026)
  11. 3.4.3 Global Haloperidol Sales by Region (2027-2032)
  12. 3.4.4 Global Haloperidol Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Haloperidol Revenue by Manufacturers
  2. 4.1.1 Global Haloperidol Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Haloperidol Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Haloperidol Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Haloperidol Sales by Manufacturers
  6. 4.2.1 Global Haloperidol Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Haloperidol Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Haloperidol Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Haloperidol Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Haloperidol Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Haloperidol Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Haloperidol Manufacturers, Product Type & Application
  13. 4.7 Global Haloperidol Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Haloperidol Market CR5 and HHI
  16. 4.8.2 2025 Haloperidol Tier 1, Tier 2, and Tier 3
5 Haloperidol Market by Type
  1. 5.1 Global Haloperidol Revenue by Type
  2. 5.1.1 Global Haloperidol Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Haloperidol Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Haloperidol Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Haloperidol Sales by Type
  6. 5.2.1 Global Haloperidol Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Haloperidol Sales by Type (2021-2032) & (Tons)
  8. 5.2.3 Global Haloperidol Sales Market Share by Type (2021-2032)
  9. 5.3 Global Haloperidol Price by Type
6 Haloperidol Market by Application
  1. 6.1 Global Haloperidol Revenue by Application
  2. 6.1.1 Global Haloperidol Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Haloperidol Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Haloperidol Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Haloperidol Sales by Application
  6. 6.2.1 Global Haloperidol Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Haloperidol Sales by Application (2021-2032) & (Tons)
  8. 6.2.3 Global Haloperidol Sales Market Share by Application (2021-2032)
  9. 6.3 Global Haloperidol Price by Application
7 Company Profiles
  1. 7.1 Teva
  2. 7.1.1 Teva Company Information
  3. 7.1.2 Teva Business Overview
  4. 7.1.3 Teva Haloperidol Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Teva Haloperidol Product Portfolio
  6. 7.1.5 Teva Recent Developments
  7. 7.2 Sandoz
  8. 7.2.1 Sandoz Company Information
  9. 7.2.2 Sandoz Business Overview
  10. 7.2.3 Sandoz Haloperidol Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Sandoz Haloperidol Product Portfolio
  12. 7.2.5 Sandoz Recent Developments
  13. 7.3 Mylan
  14. 7.3.1 Mylan Company Information
  15. 7.3.2 Mylan Business Overview
  16. 7.3.3 Mylan Haloperidol Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Mylan Haloperidol Product Portfolio
  18. 7.3.5 Mylan Recent Developments
  19. 7.4 Zydus
  20. 7.4.1 Zydus Company Information
  21. 7.4.2 Zydus Business Overview
  22. 7.4.3 Zydus Haloperidol Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Zydus Haloperidol Product Portfolio
  24. 7.4.5 Zydus Recent Developments
  25. 7.5 Gland Pharma
  26. 7.5.1 Gland Pharma Company Information
  27. 7.5.2 Gland Pharma Business Overview
  28. 7.5.3 Gland Pharma Haloperidol Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Gland Pharma Haloperidol Product Portfolio
  30. 7.5.5 Gland Pharma Recent Developments
  31. 7.6 Fresenius Kabi
  32. 7.6.1 Fresenius Kabi Company Information
  33. 7.6.2 Fresenius Kabi Business Overview
  34. 7.6.3 Fresenius Kabi Haloperidol Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Fresenius Kabi Haloperidol Product Portfolio
  36. 7.6.5 Fresenius Kabi Recent Developments
8 North America
  1. 8.1 North America Haloperidol Market Size by Type
  2. 8.1.1 North America Haloperidol Revenue by Type (2021-2032)
  3. 8.1.2 North America Haloperidol Sales by Type (2021-2032)
  4. 8.1.3 North America Haloperidol Price by Type (2021-2032)
  5. 8.2 North America Haloperidol Market Size by Application
  6. 8.2.1 North America Haloperidol Revenue by Application (2021-2032)
  7. 8.2.2 North America Haloperidol Sales by Application (2021-2032)
  8. 8.2.3 North America Haloperidol Price by Application (2021-2032)
  9. 8.3 North America Haloperidol Market Size by Country
  10. 8.3.1 North America Haloperidol Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Haloperidol Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Haloperidol Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Haloperidol Market Size by Type
  2. 9.1.1 Europe Haloperidol Revenue by Type (2021-2032)
  3. 9.1.2 Europe Haloperidol Sales by Type (2021-2032)
  4. 9.1.3 Europe Haloperidol Price by Type (2021-2032)
  5. 9.2 Europe Haloperidol Market Size by Application
  6. 9.2.1 Europe Haloperidol Revenue by Application (2021-2032)
  7. 9.2.2 Europe Haloperidol Sales by Application (2021-2032)
  8. 9.2.3 Europe Haloperidol Price by Application (2021-2032)
  9. 9.3 Europe Haloperidol Market Size by Country
  10. 9.3.1 Europe Haloperidol Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Haloperidol Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Haloperidol Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Haloperidol Market Size by Type
  2. 10.1.1 China Haloperidol Revenue by Type (2021-2032)
  3. 10.1.2 China Haloperidol Sales by Type (2021-2032)
  4. 10.1.3 China Haloperidol Price by Type (2021-2032)
  5. 10.2 China Haloperidol Market Size by Application
  6. 10.2.1 China Haloperidol Revenue by Application (2021-2032)
  7. 10.2.2 China Haloperidol Sales by Application (2021-2032)
  8. 10.2.3 China Haloperidol Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Haloperidol Market Size by Type
  2. 11.1.1 Asia Haloperidol Revenue by Type (2021-2032)
  3. 11.1.2 Asia Haloperidol Sales by Type (2021-2032)
  4. 11.1.3 Asia Haloperidol Price by Type (2021-2032)
  5. 11.2 Asia Haloperidol Market Size by Application
  6. 11.2.1 Asia Haloperidol Revenue by Application (2021-2032)
  7. 11.2.2 Asia Haloperidol Sales by Application (2021-2032)
  8. 11.2.3 Asia Haloperidol Price by Application (2021-2032)
  9. 11.3 Asia Haloperidol Market Size by Country
  10. 11.3.1 Asia Haloperidol Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Haloperidol Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Haloperidol Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Haloperidol Market Size by Type
  2. 12.1.1 SAMEA Haloperidol Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Haloperidol Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Haloperidol Price by Type (2021-2032)
  5. 12.2 SAMEA Haloperidol Market Size by Application
  6. 12.2.1 SAMEA Haloperidol Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Haloperidol Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Haloperidol Price by Application (2021-2032)
  9. 12.3 SAMEA Haloperidol Market Size by Country
  10. 12.3.1 SAMEA Haloperidol Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Haloperidol Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Haloperidol Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Haloperidol Value Chain Analysis
  2. 13.1.1 Haloperidol Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Haloperidol Production Mode & Process
  6. 13.2 Haloperidol Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Haloperidol Distributors
  9. 13.2.3 Haloperidol Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst